Evaluation of Non-pharmacological and Pharmacological Treatment for oVerweight and Obesity in pAtients of the Outpatient Register (EVA)

Evaluation of Non-pharmacological and Pharmacological Treatment for Overweight and Obesity in Patients With Cardiovascular Diseases or With High Cardiovascular Risk According to the Results of Patients' Interviews Within the Outpatient Registry

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03908216

Acronym

EVA

Enrollment

295

Registered

2019-04-09

Start date

2019-04-18

Completion date

2021-04-03

Last updated

2021-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity

Keywords

overweight,obesity,patients' survey,drug&non-drug treatment

Brief summary

A prospective non-interventional single-centre study aimed to assess the current practice of non-pharmacological treatment and pharmacological therapy of overweight and obesity in patients with cardiovascular diseases (CVD) or with a high risk of CVD according to the patients' survey data

Detailed description

To interview 300 patients with a body mass index (BMI) ≥25 kg / m² of the outpatient register, who come for a primary or secondary visit to the Center. The specifically designed questionnaire contains topics about patients' self-concept of their body mass; doctors' prescriptions of therapy for obesity, patients' adherence to recommendations. A repeated short telephone interview of these patients will be conducted in 1-1.5 years after visit inclusion to clarify the dynamics of weight and methods of its correction.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

patients of the outpatient PROFILE registry with CVD or with a high risk of CVD (≥5%), with overweight (BMI≥25 kg/m2) or obesity (BMI≥30 kg/m2). Presence of written informed consent to participate in the study, fill in the original questionnaire and given consent to the processing of personal data

Exclusion criteria

normal weight, pregnancy

Design outcomes

Primary

Measure	Time frame	Description
The proportion of patients received non-pharmacological treatment recommendations	on enrollment	Non-pharmacological methods of treatment: diet treatment, increasing physical activity
The proportion of patients received pharmacological treatment recommendations	on enrollment	Anti-obesity drug treatment prescribing
Patients' self-concept of their body mass	on enrollment	The proportion of patients who assess their weight as normal weight, overweight or obesity. Patient knowledge of obesity and overweight treatment methods

Secondary

Measure	Time frame	Description
Effect of overweight and obesity treatment	April, 2019 - November, 2020	Dynamics of the patient's body weight in a prospective observation
Patient self-assessment of previous overweight and obesity treatments effectiveness	April, 2019 - November, 2020	The proportion of patients who rated the effectiveness of treatment as effective short-term, effective long-term, ineffective

Countries

Russia

Outcome results